Research published in cardiovascular journals has shown that patients on semaglutide experienced average LDL reductions of 515% and triglyceride reductions of 1025% over 612 months
Semaglutide activates only the GLP-1 receptor, while tirzepatide activates both GLP-1 and GIP receptors, creating dual-pathway hunger suppression
Jara-Perez, and A
Symptoms include: Coma Confusion Dizziness, lightheadedness Extreme fatigue, weakness, or discomfort Fast or slow heartbeat Feeling cold, especially in your hands or feet Muscle pain Nausea, vomiting, stomach pain Numbness/tingling Rapid breathing or shortness of breath Skin flushing Sweating Tremors Potential medication interactions Some medications may increase your risk of developing serious side effects if taken with metformin
Reduced FPN and heightened iron input may contribute to renal tubular iron accumulation in CKD [31]
Others need more support, especially if they have struggled for years or if their risk profile is becoming more serious